Inquiry Basket
Inclisiran sodium is a medication approved for the treatment of people with atherosclerotic cardiovascular disease (ASCVD), ASCVD risk equivalents and heterozygous familial hypercholesterolemia (HeFH). It is a small interfering RNA (siRNA) that binds to PCSK9 messenger RNA, resulting in decreased concentrations of PCSK9 and plasma concentrations of LDL cholesterol. Research use only.
| Catalog Number | Size | Price | Stock | Quantity |
|---|---|---|---|---|
| BRC-025 | 10 mg | $2980 | In stock |